These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2014704)

  • 1. [The treatment procedure in olfactory (esthesioneurogenic) tumors].
    Aliev BM; Probatova NA
    Vopr Onkol; 1991; 37(2):215-9. PubMed ID: 2014704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Olfactory esthesioneuroma. Apropos of 12 cases].
    Lemoine C; Serrano E; Calvet H; Delisle MB; Pessey JJ
    Rev Laryngol Otol Rhinol (Bord); 1992; 113(3):185-9. PubMed ID: 1344533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory neuroblastoma: results of combined therapy.
    Tandon DA; Bahadur S; Mohanti BK; Rath GK
    Indian J Cancer; 1994 Jun; 31(2):124-9. PubMed ID: 7927445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
    Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
    Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924.
    Broich G; Pagliari A; Ottaviani F
    Anticancer Res; 1997; 17(4A):2683-706. PubMed ID: 9252701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
    Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
    Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant tumors of the nasal cavity and paranasal sinuses.
    Katz TS; Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Villaret DB
    Head Neck; 2002 Sep; 24(9):821-9. PubMed ID: 12211046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esthesioneuroblastoma: diagnosis and management.
    Newbill ET; Johns ME; Cantrell RW
    South Med J; 1985 Mar; 78(3):275-82. PubMed ID: 3975739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory esthesioneuroma: a report of 40 cases.
    Schwaab G; Micheau C; Le Guillou C; Pacheco L; Marandas P; Domenge C; Richard JM; Wibault P
    Laryngoscope; 1988 Aug; 98(8 Pt 1):872-6. PubMed ID: 3398665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
    Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgery and radiotherapy in esthesioneuroblastoma of the nose, apropos of 2 cases].
    Martínez Silla G; González Ortín M; Medina Banegas A; Spreekelsen Gasso C; López Meseguer E; Osete Albaladejo JM
    Acta Otorrinolaringol Esp; 1990; 41(2):115-7. PubMed ID: 2390295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Olfactory esthesioneuroblastoma (we present 4 cases from our service)].
    Cejas Méndez L; Martín Hernández J; Alvarez Romero E; Gil Curbelo J
    Acta Otorrinolaringol Esp; 1991; 42(3):193-7. PubMed ID: 1867911
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognostic factors in childhood sarcomas of neuroectodermal histogenesis].
    Budarin MA
    Vopr Onkol; 2002; 48(3):335-9. PubMed ID: 12455358
    [No Abstract]   [Full Text] [Related]  

  • 16. [Olfactory neuroblastoma].
    Figuerola E; Llano JA; Sánchez Palomero JM; Liern M; Adrados M
    Acta Otorrinolaringol Esp; 1988; 39(2):127-31. PubMed ID: 3078884
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical analysis of 34 cases of esthesioneuroblastoma].
    Liu WS; Tang PZ; Xu GZ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 39(6):328-32. PubMed ID: 15469075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors and outcome of esthesioneuroblastoma].
    Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
    Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.